GNMLF (Genomma Lab InternacionalB de CV) Marketable Securities : $0.0 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Genomma Lab InternacionalB de CV Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Genomma Lab InternacionalB de CV's Marketable Securities for the quarter that ended in Mar. 2025 was $0.0 Mil.

Genomma Lab InternacionalB de CV's annual Marketable Securities increased from Dec. 2022 ($10.6 Mil) to Dec. 2023 ($10.8 Mil) but then declined from Dec. 2023 ($10.8 Mil) to Dec. 2024 ($4.3 Mil).

Genomma Lab InternacionalB de CV Marketable Securities Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Marketable Securities Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

10.56

10.80

4.28

Genomma Lab InternacionalB de CV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															-	-	-	4.28	-

Genomma Lab InternacionalB de CV Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Genomma Lab InternacionalB de CV (OTCPK:GNMLF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Genomma Lab InternacionalB de CV Marketable Securities Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (OTCPK:GNMLF) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

LABB:Mexico GEKA:Germany

Address

Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.